Investment firm Zrosk buys 10% stake in Lagos-based drugmaker MeCure
MeCure said the off-market deal was finalised, following clearance from the NGX.
MeCure said the off-market deal was finalised, following clearance from the NGX.
All content is Copyrighted © 2024 The Premium Times, Nigeria
All content is Copyrighted © 2024 The Premium Times, Nigeria